Exploiting light chains for the scalable generation and platform purification of native human bispecific IgG
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exploiting light chains for the scalable generation and platform purification of native human bispecific IgG
Authors
Keywords
-
Journal
Nature Communications
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-02-12
DOI
10.1038/ncomms7113
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The CD47-SIRP signalling system: its physiological roles and therapeutic application
- (2014) Y. Murata et al. JOURNAL OF BIOCHEMISTRY
- Bispecific antibodies with native chain structure
- (2014) Romain Rouet et al. NATURE BIOTECHNOLOGY
- Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface
- (2014) Steven M Lewis et al. NATURE BIOTECHNOLOGY
- Bispecific antibodies rise again
- (2014) Ken Garber NATURE REVIEWS DRUG DISCOVERY
- Aggregation of Human Recombinant Monoclonal Antibodies Influences the Capacity of Dendritic Cells to Stimulate Adaptive T-Cell Responses In Vitro
- (2014) Verena Rombach-Riegraf et al. PLoS One
- Reshaping Antibody Diversity
- (2013) Feng Wang et al. CELL
- Bispecific antibodies for delivery into the brain
- (2013) Ryan J Watts et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Targeting T cells to tumor cells using bispecific antibodies
- (2013) Stanley R Frankel et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Bispecific antibodies with natural architecture produced by co-culture of bacteria expressing two distinct half-antibodies
- (2013) Christoph Spiess et al. NATURE BIOTECHNOLOGY
- Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange
- (2013) A. F. Labrijn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Advances in bispecific biotherapeutics for the treatment of cancer
- (2012) Chad May et al. BIOCHEMICAL PHARMACOLOGY
- The CD47–SIRPα pathway in cancer immune evasion and potential therapeutic implications
- (2012) Mark P Chao et al. CURRENT OPINION IN IMMUNOLOGY
- CDR-H3 Diversity Is Not Required for Antigen Recognition by Synthetic Antibodies
- (2012) Helena Persson et al. JOURNAL OF MOLECULAR BIOLOGY
- Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodies
- (2012) Christian Klein et al. mAbs
- Dual targeting strategies with bispecific antibodies
- (2012) Roland Kontermann mAbs
- Marketed therapeutic antibodies compendium
- (2012) Janice M. Reichert mAbs
- A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model
- (2012) Takehisa Kitazawa et al. NATURE MEDICINE
- Transfer of engineered biophysical properties between different antibody formats and expression systems
- (2012) J. V. Schaefer et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Epitope distance to the target cell membrane and antigen size determine the potency of T cell-mediated lysis by BiTE antibodies specific for a large melanoma surface antigen
- (2010) Claudia Bluemel et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM×anti-CD3) as a targeted cancer immunotherapy
- (2010) Diane Seimetz et al. CANCER TREATMENT REVIEWS
- Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
- (2010) Mark P. Chao et al. CELL
- By-passing in vitro screening—next generation sequencing technologies applied to antibody display and in silico candidate selection
- (2010) U. Ravn et al. NUCLEIC ACIDS RESEARCH
- Introducing antigen-binding sites in structural loops of immunoglobulin constant domains: Fc fragments with engineered HER2/neu-binding sites and antibody properties
- (2010) G. Wozniak-Knopp et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Rapid, simple and high yield production of recombinant proteins in mammalian cells using a versatile episomal system
- (2010) Giovanni Magistrelli et al. PROTEIN EXPRESSION AND PURIFICATION
- Mode of cytotoxic action of T cell-engaging BiTE antibody MT110
- (2009) Cornelia Haas et al. IMMUNOBIOLOGY
- Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding Site
- (2009) J. Bostrom et al. SCIENCE
- Modelling the human immune response: performance of a 1011 human antibody repertoire against a broad panel of therapeutically relevant antigens
- (2008) C. Lloyd et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Tumor Regression in Cancer Patients by Very Low Doses of a T Cell-Engaging Antibody
- (2008) R. Bargou et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started